Antimicrobial resistant bacteria are present in newborns after just a few hours of life and they help to understand the routes of transmission of antibiotic-resistance genes.
👉 https://t.co/ChBwnKnAQY
Discover in this study results highlighting the importance of incorporating the human gut microbiome in our understanding of SARS-CoV-2 infection and disease progression.
👉 https://t.co/dGieYadVj3
SARS-CoV-2: A new study published in Gut Microbes underscored the significance of fiber-fermenting gut bacteria that release short-chain fatty acids, which limit viral entry and hypercoagulation and induce an immune-mediated antiviral response.
https://t.co/uIjglOEIEY
The idea behind Live Bacterial Therapeutics (LBTs) is to engineer bacterial hosts to produce therapeutics able to repair or restore healthy microbial function and diversity.
👉Read more in this article https://t.co/qbR0fgpZ3a
This study explores how nourishing gut bacteria with the right foods will generate the necessary short-chain fatty acids that protect against, or reduce, symptoms in a variety of conditions.
https://t.co/f6YBR0wZJI
This study demonstrates that gut bacteria help the immune system recover from stem cell transplants by nurturing two special types of immune cells that protect against complications.
https://t.co/kyEugTKBNV
In this recent study published in the journal Advanced Science, researchers explored the dynamic changes in the respiratory tract and gut microbiota in COVID-19 patients.
Find out more: https://t.co/8RRsdAUTQ5
Discover how YSOPIA Bioscience unleashes microbiome-based biotherapies and join us in our journey to fight diseases such as #obesity, #crohndisease, metabolic diseases, cancer
👉 https://t.co/YXrnYk8KWP
Discover findings providing insight into the respiratory tract and gut microbial dynamics during COVID-19 progression, considering disease severity, potentially contributing to diagnosis, and treatment strategies.
Find our more: https://t.co/6zB2GODsEN
Humans living an urbanized lifestyle in industrialized countries tend to have less diverse microbiota than people living more rural existences. Find out more in this study https://t.co/1eXRu3unN9
📅 Meet us at Microbiome Connect in Amsterdam.
Fréderic Elustondo, Senior Director of Operations, will discuss the preparation of our christensenella minuta-based anaerobic bacteria Xla1 for clinical trial.
Join Fréderic on July 6th at 3.20pm
More info: https://t.co/WIrirb6eE9
[ #WorldMicrobiomeDay ] As a clinical-stage biotech leading next-generation microbiome-based living biotherapies, YSOPIA Bioscience is proud to be part of the visionary minds of the Future of the Microbiome!
Scientists find your gut is significantly different from #hunter-gather communities and the difference starts to emerge as early as six months since birth.
#Read more : https://t.co/Kv96wxX6jt
Type 2 diabetes is a highly prevalent metabolic disorder.
💡 Discover how YSOPIA Bioscience harness the potential of Christensenella gut bacteria to treat obesity and associated metabolic diseases.
https://t.co/GTcvbhqP9C
People with #Parkinson’s disease appear to have a gut microbiome — the population of microorganisms living in the intestines — that is shifted toward a pro-inflammatory state, a small study suggests.
Find out more about the study : https://t.co/wJq9RIcuVS
[#NEWS] 📢 Discover the recent scientific publication "Robust variation in infant #gut#microbiome assembly across a spectrum of lifestyles" from @ScienceMagazine
➡https://t.co/S2oqbehmhO